Grants for State governments - Health

This grant provides funding for collaborative research projects that investigate how RNA modifications influence cancer development by altering protein synthesis, requiring expertise in RNA biology and cancer research.

This funding opportunity supports innovative research to develop combination cancer therapies that integrate radiation treatment with targeted molecular agents, aimed at improving treatment effectiveness while reducing side effects.

This funding opportunity supports the establishment of Clinical Coordinating Centers for multi-site clinical trials focused on heart, lung, and blood health issues, encouraging collaboration and community engagement to improve trial efficiency and address health disparities.

The purpose of this Notice of Funding Opportunity (NOFO) is to support formative research and pilot testing of culturally sensitive, innovative interventions to identify and mitigate the risk of suicidal ideation and behavior (SIB), and/or non-suicidal self-injury (NSSI) in Low- and Middle-Income Countries (LMICs). The proposed research initiatives must incorporate a plan to strengthen research capacity within the LMIC community where the study will be conducted.

This grant provides funding for researchers, especially those new to the field or looking to integrate advanced data science methods, to explore addiction-related questions using existing data and innovative analytical techniques.

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.

The FY 2024 Strategic Prevention Framework-Partnerships for Success (SPF-PFS) for States funding opportunity, managed by SAMHSA’s Center for Substance Abuse Prevention, is designed to assist states in building prevention capacities to reduce substance misuse and related behavioral health issues. This program specifically targets communities facing high risks of substance misuse by supporting the development and delivery of evidence-based, data-driven prevention services at the state and community levels. By leveraging the Strategic Prevention Framework (SPF), this initiative prioritizes underage drinking, opioid misuse, and other substance use concerns. The funding emphasizes the involvement of underserved communities, which includes racial, ethnic, and geographic groups systematically denied access to necessary resources and services. Eligible applicants are U.S. states, territories, Pacific jurisdictions, and the District of Columbia. The funding opportunity is not open to entities that have previously received SPF-PFS funds under specific past awards to avoid redundancy in funding. For FY 2024, SAMHSA will distribute a total of $15.5 million across approximately 12 awards, with each award offering up to $1.25 million annually over a five-year period, contingent on available appropriations. Applications are due by February 21, 2024, with anticipated project start dates of September 30, 2024. Required activities include assessing community needs, building partnerships, collecting and analyzing data, and implementing community-level health assessments. States are expected to create a statewide community health improvement plan that aligns with prevention priorities identified through these assessments. At least 60% of each award must be directed to subrecipient communities that demonstrate a need for programming in chosen priority areas. The SPF process involves five main steps—assessment, capacity building, planning, implementation, and evaluation—plus guiding principles of cultural competence and sustainability. States must ensure coordination with other community-based recipients of SPF-PFS funding and leverage partnerships with the Prevention Technology Transfer Center for technical support. Applications must include a project narrative limited to 10 pages, detailing the project’s goals, objectives, required activities, and a budget justification. SAMHSA requires a dedicated Project Director and Data Analyst with specific time commitments. A letter to the Single State Agency, confidentiality protocols, and biographical sketches are also required. Bonus points are available for applicants demonstrating a focus on underserved populations, making up at least 50% of the population served. Data collection will follow the Government Performance and Results Modernization Act, with performance data submitted quarterly via SAMHSA’s reporting system (SPARS). Evaluation criteria for the grant include feasibility, organizational capacity, project alignment with program goals, cost-effectiveness, and commitment to behavioral health equity. Applicants must provide documentation of their efforts to identify and address health disparities in the populations served. Grant recipients must report on performance quarterly and annually, including progress in underserved communities and efforts to reduce behavioral health disparities.

This funding opportunity supports researchers developing and testing strategies to prevent fetal alcohol spectrum disorders and improve interventions for affected individuals throughout their lives.

This funding opportunity supports research projects that explore how patients' beliefs and expectations about cancer treatment can improve symptom management, particularly for underserved populations facing unique challenges in care.

The "Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research" grant aims to support educational activities and hands-on research experiences that encourage clinicians, particularly those from diverse backgrounds, to pursue research careers in biomedical, behavioral, and clinical sciences, with a focus on areas relevant to the National Institute on Deafness and Other Communication Disorders (NIDCD).

This funding opportunity provides financial support to various organizations, including health centers and nonprofits, to implement evidence-based strategies that increase colorectal cancer screening rates among underserved populations aged 45 to 75.

This program provides financial assistance to state and local agencies, victim service organizations, and non-profits to support victims of terrorism and mass violence through compensation and crisis response services.

This funding opportunity supports researchers in developing and optimizing neurophysiological measures to improve the treatment development process for mental disorders in both humans and relevant animal species.

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.

This grant provides preclinical support services to researchers developing innovative HIV therapies and addressing related health issues, enabling them to advance their drug development efforts.

This grant provides funding for researchers to conduct early-stage clinical trials aimed at improving treatments for patients with arthritis, musculoskeletal, or skin diseases.

This funding opportunity provides financial support for researchers and institutions to develop and optimize animal models that assess brain circuit engagement, aiming to improve therapeutic approaches for mental health conditions.

This funding opportunity supports interdisciplinary teams in developing innovative 3D tissue systems that model human aging processes for research and drug discovery.

The purpose of this Notice is to announce the intention of National Institutes of Neurological Disorders and Stroke (NINDS) to reissue RFA-NS-21-021 to solicit applications for research pursuing translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the R61/R33 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides $2 million to support innovative research projects focused on developing resources and strategies for preventing firearm injuries, targeting a wide range of eligible organizations including nonprofits, educational institutions, and government entities.